<DOC>
	<DOCNO>NCT00526474</DOCNO>
	<brief_summary>The study design determine whether vorapaxar , add exist standard care ( SOC ) prevent heart attack stroke ( eg , aspirin , clopidogrel ) participant know history atherosclerosis , yield additional benefit exist standard care without vorapaxar prevent heart attack stroke . The study also design assess risk bleed vorapaxar add standard care versus standard care alone .</brief_summary>
	<brief_title>Trial Assess Effects Vorapaxar ( SCH 530348 ; MK-5348 ) Preventing Heart Attack Stroke Patients With Atherosclerosis ( TRA 2Â°P - TIMI 50 ) ( P04737 )</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Vorapaxar</mesh_term>
	<criteria>Men woman least 18 year old evidence history atherosclerosis involve coronary , cerebral , peripheral vascular system one follow : history myocardial infarction ( heart attack ) history ischemic stroke ( stroke due block artery ) history peripheral arterial disease history intracranial hemorrhage central nervous system ( CNS ) surgery , tumor , aneurysm bleed disorder abnormality sustain severe hypertension valvular heart disease current recent platelet count &lt; 100,000 mm^3 plan ongoing treatment blood thin medication pregnancy significant medical physiological condition abnormality could put subject increase risk limit subject 's ability participate duration study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>